ALKBH5 and intrahepatic cholangiocarcinoma: Additionally, ALKBH5 regulated TIME by inhibiting the infiltration of MDSC-like cells and promoting PD-L1 expression on monocyte/macrophage cells via YTHDF2 in intrahepatic cholangiocarcinoma (ICC) [95].